EDQM Sets 2023 Target For Modernizing ‘Certificates Of Suitability’
Executive Summary
The European Directorate for the Quality of Medicines & HealthCare is proceeding carefully to find the right balance between serving the diverse requirements of various stakeholders that make use of its ‘certificates of suitability.’
You may also be interested in...
EDQM Plans ‘Certificates Of Suitability’ Makeover
The European Directorate for the Quality of Medicines & HealthCare has launched a project to redesign its “certificates of suitability” to better respond to the needs of drug makers and regulatory authorities in terms of providing relevant information on active substances.
The EU's Top Valsartan Lesson: Closely Examine Active Substance Manufacturing Processes
EU report on “lessons learnt” from the valsartan crisis calls for tighter GMP controls on API suppliers.
EMA To Explain How Trial Transparency & Data Redaction Can Live Together
The European Medicines Agency is working to align the redaction and data anonymization principles underpinning two EU clinical trial transparency initiatives to ensure consistency in disclosure requirements.